![Peter Olagunju](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Olagunju
Verkställande Direktör på
ImmunoSCAPE Pte Ltd.
Profil
Mr. Peter Olagunju is a Chief Executive Officer at ImmunoScape Pte Ltd. and a Chairman at March Biosciences, Inc. Mr. Olagunju was previously employed as a Chief Operating Officer by TCR² Therapeutics, Inc., a Senior Vice President-Technical Operations by FerGene, Inc., a Vice President-Global Patient Operations by bluebird bio, Inc., a Head-Quality by Dendreon Corp., and a Head-Quality by ZymoGenetics, Inc. He received his undergraduate degree from the University of Illinois At Urbana–Champaign and an MBA from Foster School of Business.
Aktiva positioner av Peter Olagunju
| Företag | Position | Start |
|---|---|---|
ImmunoSCAPE Pte Ltd.
 ImmunoSCAPE Pte Ltd. BiotechnologyHealth Technology Operates as a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T cell therapies | Verkställande Direktör | 2026-09-23 |
Tidigare kända positioner av Peter Olagunju
| Företag | Position | Slut |
|---|---|---|
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer | Företagsledare/Principal | 2021-07-01 |
| GENETIX BIOTHERAPEUTICS, INC. | Företagsledare/Principal | 2020-03-01 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Företagsledare/Principal | - |
| DENDREON CORPORATION | Företagsledare/Principal | - |
| TCR2 THERAPEUTICS INC. | Verksamhetschef | - |
Peter Olagunjus utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
51
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunoSCAPE Pte Ltd.
ImmunoSCAPE Pte Ltd. BiotechnologyHealth Technology Operates as a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T cell therapies | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer | Health Technology |
Foster School of Business
 Foster School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
